These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 401975)

  • 21. [The development of calcium metabolic disorders in patients in the terminal stage of chronic kidney failure receiving hemodialysis treatment].
    Kalashnikov AIa; Kon'kova TA; Popovkin NN; Iarmolinskiĭ IS
    Urol Nefrol (Mosk); 1989; (3):46-52. PubMed ID: 2773181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 23. [X-ray observations of the bone demineralization process in chronic alcoholism].
    Freidĭn LM; Ionkis IaG
    Vestn Rentgenol Radiol; 1977; (3):63-8. PubMed ID: 883121
    [No Abstract]   [Full Text] [Related]  

  • 24. [Novel active analogues of vitamin D3 for therapy of secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].
    Kobayashi T; Nishii Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():715-9. PubMed ID: 1808341
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endocrine bone diseases morphology, histomorphometry and differential diagnosis (author's transl)].
    Delling G
    Veroff Pathol; 1975; (98):1-111. PubMed ID: 785861
    [No Abstract]   [Full Text] [Related]  

  • 26. [Contemporary opinions on the diagnosis and treatment of secondary hyperparathyroidism].
    Zawierucha J; Małyszko J; Małyszko J; Prystacki T; Marcinkowski W; Dryl-Rydzyńska T
    Przegl Lek; 2016; 73(7):497-503. PubMed ID: 29677420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dental management for children with chronic renal failure undergoing hemodialysis therapy.
    Chow MH; Peterson DS
    Oral Surg Oral Med Oral Pathol; 1979 Jul; 48(1):34-8. PubMed ID: 287985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from intravenous maxacalcitol to oral vitamin D in secondary hyperparathyroidism management.
    Tanemoto M; Katsuoka Y
    Clin Exp Nephrol; 2022 Jan; 26(1):97-98. PubMed ID: 34549338
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 31. [Extraskeletal actions of parathyroid hormone in hemodialysis patients].
    Okuno S
    Clin Calcium; 2004 Jan; 14(1):27-31. PubMed ID: 15576950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
    Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
    Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Abnormalities in parathyroid hormone and calcitonin associated with uremia].
    Okazaki R
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():169-72. PubMed ID: 15250289
    [No Abstract]   [Full Text] [Related]  

  • 35. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
    Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
    J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brown tumor at the jaw in patients with secondary hyperparathyroidism due to chronic renal failure.
    Pechalova PF; Poriazova EG
    Acta Medica (Hradec Kralove); 2013; 56(2):83-6. PubMed ID: 24069663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiological features of abnormal calcium metabolism in dialysis patients (author's transl)].
    Ritz E; Kuhn HM; Krempien B; Heuck F; Müller W; Kerlé W; Aschermann C
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Aug; 119(2):194-202. PubMed ID: 4357583
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative importance of parathyroid hormone and thyrocalcitonin in calcium homeostasis.
    Sherwood LM
    N Engl J Med; 1968 Mar; 278(12):663-70. PubMed ID: 5637251
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of vitamin D in the pathogenesis of renal osteodystrophy].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.